← Leaderboards
Konstantinos Votanopoulos
Wake Forest University Health Sciences
$2,216,499
Attributed
$4,432,998
Total exposure
2
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1M · FY2021–25$2M$1.5M$1M$500K$0
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$4,432,998 · 2
By mechanism
R01$4,432,998 · 2
Top collaborators
- Lance David Miller9 shared
Most similar at Wake Forest University Health Sciences
Same institution · by research overlap
- Lance David Miller$2,718,111
Others in their field
Other Emerging Leaders on “Operative Surgical Procedures”
- Sonia M Thomas · Research Triangle Institute$701,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- Leonard Freedman · Leidos Biomedical Research, Inc.$63,381,339
- Leonard Freedmand · Leidos Biomedical Research, Inc.$52,916,621
- Craig Reist · Research Triangle Institute$22,725,934
- Lisa Newman · Research Triangle Institute$22,725,934
Research focus
Operative Surgical ProceduresMutationGenotypeGenesMalignant NeoplasmsMalignant Neoplasm Of Gastrointestinal TractDrug ResistanceDna Sequence AlterationDrug SensitivityGene MutationIntraperitoneal TherapyBiopsyMalignant Neoplasm Of AppendixCancer PatientChemoresistanceChemotherapyColon CarcinomaDesignAnatomyDrug ScreeningDrug TestingExhibitsCharacteristicsOrganoids
Grant awards (9)
Tumor Organoid-Mediated Drug Testing and Clonality Analysis in Peritoneal Surface Disease of Intestinal Origin$494,107
R01 · FY2025 · CA · contact PI
Establishing the Repertoire of Actionable Alterations in Appendiceal Adenocarcinoma$477,793
R01 · FY2025 · CA
Tumor Organoid-Mediated Drug Testing and Clonality Analysis in Peritoneal Surface Disease of Intestinal Origin$478,598
R01 · FY2024 · CA · contact PI
Establishing the Repertoire of Actionable Alterations in Appendiceal Adenocarcinoma$473,282
R01 · FY2024 · CA
Establishing the Repertoire of Actionable Alterations in Appendiceal Adenocarcinoma$505,425
R01 · FY2023 · CA
Tumor Organoid-Mediated Drug Testing and Clonality Analysis in Peritoneal Surface Disease of Intestinal Origin$494,277
R01 · FY2023 · CA · contact PI
Establishing the Repertoire of Actionable Alterations in Appendiceal Adenocarcinoma$513,418
R01 · FY2022 · CA
Tumor Organoid-Mediated Drug Testing and Clonality Analysis in Peritoneal Surface Disease of Intestinal Origin$494,928
R01 · FY2022 · CA · contact PI
Tumor Organoid-Mediated Drug Testing and Clonality Analysis in Peritoneal Surface Disease of Intestinal Origin$501,170
R01 · FY2021 · CA · contact PI